Bridgebio Pharma Inc
(BBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,732 | -484,652 | -344,082 | -203,889 | -201,330 |
| Depreciation Amortization | 1,633 | 6,771 | 5,111 | 3,466 | 1,884 |
| Accounts payable and accrued liabilities | -3,800 | -349 | -1,725 | -3,090 | -1,814 |
| Other Working Capital | -31,802 | 28,079 | 16,331 | 23,202 | -10,075 |
| Other Operating Activity | 32,379 | 30,657 | -1,886 | -10,777 | 50,700 |
| Operating Cash Flow | $-144,322 | $-419,494 | $-326,251 | $-191,088 | $-160,635 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -4,821 | -4,020 | -3,261 | -859 |
| Purchase Of Investment | -47,474 | -193,055 | -160,947 | -130,541 | -63,884 |
| Sale Of Investment | 60,287 | 532,523 | 481,649 | 303,627 | 193,366 |
| Purchase Sale Intangibles | N/A | -1,500 | -1,500 | -1,500 | N/A |
| Other Investing Activity | -503 | 118,500 | 118,500 | 118,500 | 10,000 |
| Investing Cash Flow | $12,298 | $453,147 | $435,182 | $288,325 | $138,623 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -20,486 | -20,486 | -20,486 | N/A |
| Common Stock Issued | 145,018 | 8,076 | 3,167 | 1,126 | 1,070 |
| Common Stock Repurchased | -512 | -1,561 | -1,072 | -476 | -110 |
| Other Financing Activity | 5,743 | 837 | -1,120 | -1,120 | -1,120 |
| Financing Cash Flow | $150,249 | $-13,134 | $-19,511 | $-20,956 | $-160 |
| Beginning Cash Position | 416,884 | 396,365 | 396,365 | 396,365 | 396,365 |
| End Cash Position | 435,109 | 416,884 | 485,785 | 472,646 | 374,193 |
| Net Cash Flow | $18,225 | $20,519 | $89,420 | $76,281 | $-22,172 |
| Free Cash Flow | |||||
| Operating Cash Flow | -144,322 | -419,494 | -326,251 | -191,088 | -160,635 |
| Capital Expenditure | -12 | -4,821 | -4,020 | -3,261 | -859 |
| Free Cash Flow | -144,334 | -424,315 | -330,271 | -194,349 | -161,494 |